Effects of stimulants on the continuous performance test (CPT): Implications for CPt use and interpretation

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 13, Issue 3, 2001, Pages 326-335

  Riccio, C A ^a   Waldrop, J J M ^a   Reynolds, C R ^a   Lowe, P ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CENTRAL STIMULANT AGENT; METHYLPHENIDATE; NICOTINE; PSYCHOSTIMULANT AGENT;

ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; DRUG EFFECT; HUMAN; PERFORMANCE; PRIORITY JOURNAL; TASK PERFORMANCE; TREATMENT OUTCOME;

EID: 0034871852     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.13.3.326     Document Type: Article

References (109)

1. Stimulant medications
2. Prevalence of drug therapy
3. A survey of medication treatment for hyperactive/inattention students
4. Hyperactivity and inattentiveness: School assessment of stimulant treatment
5. Increased methylphenidate usage for attention deficit disorder in the 1990s
6. Summary of the practice parameters for the assessment and treatment of children, adolescents and adults with ADHD
7. Measures of cognitive functioning appropriate for use in pediatric psychopharmacological research studies
8. Multimethod assessment of attention deficit hyperactivity disorder: The diagnostic utility of clinic-based tests
9. Drugs, learning, and the psychotherapies
10. The use of a simple test of attention as a measure of drug effects in schizophrenic patients
11. The continuous performance test in learning disabled and nondisabled children
12. Fenfluramine and methylphenidate in children with mental retardation and attention deficit hyperactivity disorder: Laboratory effects
13. Cognitive processes in normal and hyperactive children and their response to amphetamine treatment
14. A controlled trial of stimulant medication in children with the fragile X syndrome
15. The effects of attention training on information processing in schizophrenia
16. Methylphenidate: Effects on sustained attention
17. A continuous performance test of brain damage
18. Attentional measures in a study of children at high risk for schizophrenia
19. Response of phenylketonuric children on a continuous performance test
20. Continuous performance tests in schizophrenic patients: Stimulus and medication effects on performance
21. Effects of methylphenidate on adolescents with a childhood history of attention deficit disorder, II: Information processing
22. Effects of sustained release and standard preparations of methylphenidate on attention deficit disorder
23. A computerized assessment battery for attention deficits
24. The Continuous Performance Test, identical pairs version (CPT-IP), II: Contrasting attentional profiles in schizophrenia and depressed patients
25. The Continuous Performance Test, identical pairs version (CPT-IP), III: Brain functioning during performance of numbers and shapes subtasks
26. The performance of hyperactive and control preschoolers on a new computerized measure of visual vigilance: The Preschool Vigilance Task
27. Performance of disabled and normal readers on the Continuous Performance Test
28. Effects of event rate and display time on sustained attention in hyperactive, normal, and control children
29. Glucose metabolic rate in normals and schizophrenics during the Continuous Performance Test assessed by positron emission tomography
30. Selegiline in ADHD adults: Plasma monamines and monamine metabolites
31. The hyperactive child at adolescence: Cognitive, emotional, and social functioning
32. Sustained attention in children at risk for schizophrenia: Report on a continuous performance test
33. Blunted catecholamine responses after glucose ingestion in children with attention deficit disorder
34. Sustained deficits in patients with frontal lesions
35. Signal detection in vigilance tasks and behavioral attributes of schizophrenic mothers and among hyperactive children
36. Hyperactive and hypoxic children: Signal detection, sustained attention, and behavior
37. Effects of methylphenidate on attention-deficit hyperactivity disorder with and without aggressive/noncompliant features
38. Relations among sustained attention, reading performance, and teachers' ratings of behavior problems
39. Signal detection theory in the analysis of human vigilance
40. Memory load and event rate control sensitivity decrements in sustained attention
41. Sensitivity and specificity of CPT in diagnosis of ADHD: Much of one and none of the other
42. Catecholamines and attention, I: Animal and clinical studies
43. Catecholamines and attention, II: Pharmacological studies in normal humans
44. Neurobiology of attention deficit disorder with hyperactivity: Where have we come in 50 years?
45. A possible pathophysiological substrate of attention deficit hyperactivity disorder
46. The dopamine theory of attention deficit hyperactivity disorder (ADHD)
47. Isolating attentional systems: A cognitive-anatomical analysis
48. The efficacy of stimulant drug treatment for hyperactivity: A meta-analysis
49. Error patterns of the continuous performance test in non-medicated and medicated samples of children with and without ADHD: A meta-analytic review
50. An investigation into the possibility of irreversible central nervous system damage as a result of long-term chlorpromazine medication
51. Integrating findings: The meta-analysis of research
52. Stimulants
53. Relative efficacy of long-acting stimulant on children with attention deficit and hyperactivity disorder: A comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine and pemoline
54. Attention deficits in school-aged children and adolescents: Current issues and practice
55. Pharmacotherapy for children with attention deficit hyperactivity disorder
56. A review of stimulant drug research with hyperactive children
57. Clinical effects of a controlled trial of methylphenidate on adolescents with attention deficit disorder
58. The measurement of hyperactive syndrome in children
59. Psychostimulants and children: A review and analysis
60. Pediatricians' knowledge and attitudes concerning diagnosis and treatment of attention deficit and hyperactivity disorders: A national survey approach
61. Inhibition and attention deficit hyperactivity disorder
62. Ineffectiveness of imipramine in children who fail to respond to methylphenidate
63. Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate
64. Methylphenidate and cognitive therapy with ADD children: A methodological reconsideration
65. Development of a multimethod clinical protocol for assessing stimulant drug response in children with attention deficit disorder
66. Psychological effects of stimulant drugs in children with minimal brain dysfunction
67. Efficacy of methylphenidate among mentally retarded children with attention deficit hyperactivity disorder
68. Effects of two doses of methylphenidate on cross-situational and borderline hyperactive children's evoked potentials
69. Normalizing effects of methylphenidate on hyperactive children's vigilance performance and evoked potentials
70. Attention-deficit hyperactivity disordered boys' evaluations of and attributions for task performance on medication versus placebo
71. Effects of methylphenidate on preschool children with ADHD: Cognitive and behavioral functions
72. Effects of methylphenidate and performance in memory scanning and vigilance
73. Methylphenidate and desipramine in hospitalized children, I: Separate and combined effects on cognitive function
74. Comparing classroom and clinic measures of attention deficit disorder: Differential, idiosyncratic, and dose-response effects of methylphenidate
75. Effects of methylphenidate and behavioral contingencies on sustained attention in attention deficit hyperactivity disorder: A test of the reward dysfunction hypothesis
76. The effect of methylphenidate (Ritalin) on sustained attention in hyperactive children
77. Attention in hyperactive children and the effects of methylphenidate (Ritalin)
78. Methylphenidate influences on both early and late ERP waves of ADHD children in a continuous performance test
79. Methylphenidate in hyperactive and enuretic children
80. Effects of sodium valproate on psychomotor performance in children as a function of dose fluctuations in concentration and diagnosis
81. Methylphenidate and thioridazine in the treatment of intellectually subaverage children: Effects on cognitive-motor performance
82. The response of aggressive and non-aggressive attention deficit and hyperactivity disorder children to two doses of methylphenidate
83. Methylphenidate speeds evaluation processes of attention deficit disorder adolescents during a continuous performance test
84. Imipramine and methylphenidate in hyperactive children
85. Pemoline, methylphenidate, and placebo in children with minimal brain dysfunction
86. Effects and noneffects of methylphenidate in children with mental retardation and ADHD
87. Effects of methylphenidate in normal adults with reference to drug action in hyperactivity
88. A controlled trial of methylphenidate in black adolescents
89. Alterations in vigilance performance of children receiving amitriptyline and methylphenidate pharmacotherapy
90. Stimulant drugs and vigilance performance: A review
91. Effects of amphetamine on vigilance performance in normal and hyperactive children
92. Caffeine effects on learning, performance, and anxiety in normal school-aged children
93. 12- and 24-month neurobehavioural follow-up of children prenatally exposed to marihuana, cigarettes and alcohol
94. Nicotine effects on adults with attention-deficit/hyperactivity disorder
95. Transdermal nicotine effects on attention
96. Nicotine-haloperidol interactions and cognitive performance in schizophrenics
97. Attention deficit disorder and methylphenidate: Group and single subject analyses of dose effects on attention in clinic and classroom settings
98. Familial association between attention deficit disorder and anxiety disorders
99. Long term treatment with ADD children: A call for more research